IN2014MN00377A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN00377A IN2014MN00377A IN377MUN2014A IN2014MN00377A IN 2014MN00377 A IN2014MN00377 A IN 2014MN00377A IN 377MUN2014 A IN377MUN2014 A IN 377MUN2014A IN 2014MN00377 A IN2014MN00377 A IN 2014MN00377A
- Authority
- IN
- India
- Prior art keywords
- complex
- metalloproteinase inhibitor
- relates
- renal
- kda
- Prior art date
Links
- 206010061481 Renal injury Diseases 0.000 abstract 3
- 102100026262 Metalloproteinase inhibitor 2 Human genes 0.000 abstract 2
- 108050006602 Metalloproteinase inhibitor 2 Proteins 0.000 abstract 2
- 102000017304 72kDa type IV collagenases Human genes 0.000 abstract 1
- 108050005269 72kDa type IV collagenases Proteins 0.000 abstract 1
- 102100022712 Alpha-1-antitrypsin Human genes 0.000 abstract 1
- 101710181333 Chaperone protein dnaK1 Proteins 0.000 abstract 1
- 101710089247 Heat shock 70 kDa protein 1 Proteins 0.000 abstract 1
- 101710093639 Heat shock 70 kDa protein 1A Proteins 0.000 abstract 1
- 102100040352 Heat shock 70 kDa protein 1A Human genes 0.000 abstract 1
- 101710093640 Heat shock 70 kDa protein 1B Proteins 0.000 abstract 1
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 abstract 1
- 101710184277 Insulin-like growth factor 1 receptor Proteins 0.000 abstract 1
- 108010028275 Leukocyte Elastase Proteins 0.000 abstract 1
- 102000016799 Leukocyte elastase Human genes 0.000 abstract 1
- 102000000422 Matrix Metalloproteinase 3 Human genes 0.000 abstract 1
- 108010016160 Matrix Metalloproteinase 3 Proteins 0.000 abstract 1
- 102100024134 Myeloid differentiation primary response protein MyD88 Human genes 0.000 abstract 1
- 101710112096 Myeloid differentiation primary response protein MyD88 Proteins 0.000 abstract 1
- 102100021852 Neuronal cell adhesion molecule Human genes 0.000 abstract 1
- 101710130688 Neuronal cell adhesion molecule Proteins 0.000 abstract 1
- 102100024598 Tumor necrosis factor ligand superfamily member 10 Human genes 0.000 abstract 1
- 101710097160 Tumor necrosis factor ligand superfamily member 10 Proteins 0.000 abstract 1
- 108010050122 alpha 1-Antitrypsin Proteins 0.000 abstract 1
- 229940024142 alpha 1-antitrypsin Drugs 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000000104 diagnostic biomarker Substances 0.000 abstract 1
- 208000037806 kidney injury Diseases 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 239000000092 prognostic biomarker Substances 0.000 abstract 1
- 238000011269 treatment regimen Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Surgery (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161528003P | 2011-08-26 | 2011-08-26 | |
| US201161528000P | 2011-08-26 | 2011-08-26 | |
| PCT/US2012/052298 WO2013043310A1 (fr) | 2011-08-26 | 2012-08-24 | Méthodes et compositions de diagnostic et de pronostic de lésions rénales et de l'insuffisance rénale |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN00377A true IN2014MN00377A (fr) | 2015-06-19 |
Family
ID=47914751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN377MUN2014 IN2014MN00377A (fr) | 2011-08-26 | 2012-08-24 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US9459261B2 (fr) |
| EP (2) | EP2748605B1 (fr) |
| JP (2) | JP2014529073A (fr) |
| KR (1) | KR20140074307A (fr) |
| CN (2) | CN103874923B (fr) |
| AU (1) | AU2012312907A1 (fr) |
| BR (1) | BR112014004389A2 (fr) |
| CA (1) | CA2846602A1 (fr) |
| EA (1) | EA201490384A1 (fr) |
| ES (1) | ES2721907T3 (fr) |
| IN (1) | IN2014MN00377A (fr) |
| MX (1) | MX346096B (fr) |
| PL (1) | PL2748605T4 (fr) |
| PT (1) | PT2748605T (fr) |
| TR (1) | TR201903235T4 (fr) |
| WO (1) | WO2013043310A1 (fr) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ607703A (en) | 2008-10-21 | 2014-09-26 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| JP5763098B2 (ja) | 2009-12-20 | 2015-08-12 | アスチュート メディカル，インコーポレイテッド | 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 |
| NZ605698A (en) | 2010-06-23 | 2015-03-27 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CN103874923B (zh) * | 2011-08-26 | 2016-09-14 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断及预后的方法和组合物 |
| ES2734494T3 (es) | 2011-12-08 | 2019-12-10 | Astute Medical Inc | Métodos y usos para el diagnóstico de una lesión renal y de una insuficiencia renal |
| TR201807542T4 (tr) | 2013-01-17 | 2018-06-21 | Astute Medical Inc | Böbrek hasarı ve böbrek yetmezliği teşhisi ve prognozuna yönelik metotlar ve bileşimler. |
| US10983136B2 (en) * | 2013-01-28 | 2021-04-20 | Diasorin S.P.A. | Use of 1,25-dihydroxyvitamin D values in ratio with PTH as a prognostic biomarker |
| WO2016113720A1 (fr) * | 2015-01-18 | 2016-07-21 | Diasorin S.P.A. | Utilisation de valeurs 1,25-dihydroxyvitamine d dans un rapport avec la pth en tant que biomarqueur pronostique |
| US11261257B2 (en) | 2013-01-28 | 2022-03-01 | Diasorin S.P.A. | Methods for detecting 1,25-dihydroxyvitamin D and related antibodies |
| PL2759550T3 (pl) | 2013-01-28 | 2019-01-31 | Diasorin S.P.A. | Sposób i zestaw do wykrywania 1,25-dihydroksywitaminy D i powiązane przeciwciała |
| US10300108B2 (en) | 2013-12-03 | 2019-05-28 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CN107003301B (zh) * | 2014-10-20 | 2019-11-01 | 阿斯图特医药公司 | 用于诊断和预后肾损伤和肾衰竭的方法和组合物 |
| US11243202B2 (en) | 2015-04-09 | 2022-02-08 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CN105466984B (zh) * | 2016-01-14 | 2018-12-28 | 郑以山 | 用于肾脏非显性损伤的预警装置及其使用方法 |
| EP3465201A4 (fr) | 2016-06-06 | 2020-08-26 | Astute Medical, Inc. | Prise en charge de lésions rénales aiguës au moyen de la protéine de liaison de facteur de croissance insulinomimétique 7 et de l'inhibiteur tissulaire de métalloprotéinase 2 |
| JP2020504157A (ja) | 2017-01-12 | 2020-02-06 | アスチュート メディカル，インコーポレイテッド | Ｃ−ｃモチーフケモカインリガンド１４の測定に基づく腎損傷および腎不全の評価および処置のための方法および組成物 |
| US11346846B2 (en) | 2017-02-06 | 2022-05-31 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| US11718682B2 (en) | 2017-04-05 | 2023-08-08 | Astute Medical, Inc. | Assays for TIMP2 having improved performance in biological samples |
| KR20210019459A (ko) | 2018-05-24 | 2021-02-22 | 레니버스 테라퓨틱스, 인크. | 신장 손상 및 신부전 위험이 있는 환자를 치료하는 방법 |
| CN109251956A (zh) * | 2018-09-18 | 2019-01-22 | 青岛大学 | 糖尿病大鼠胰岛内MyD88 mRNA表达及黄芪的调节作用 |
| US20220178946A1 (en) * | 2018-11-02 | 2022-06-09 | Prevencio, Inc. | Prognostic and diagnostic methods for risk of acute kidney injury |
| CN114113575B (zh) * | 2020-08-28 | 2023-06-02 | 菲鹏生物股份有限公司 | 标记复合物及其制备方法与应用 |
| CN116434960B (zh) * | 2023-06-13 | 2023-10-13 | 中国人民解放军总医院 | 一种心源性休克临床决策支持系统、设备及可存储介质 |
| WO2025033619A1 (fr) * | 2023-08-07 | 2025-02-13 | 경상국립대학교병원 | Procédé de fourniture d'informations pour déterminer l'initiation d'une suppléance rénale, et composition de diagnostic de maladie rénale de stade final pour déterminer celle-ci |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5028535A (en) | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
| US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
| US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
| CA2072758A1 (fr) | 1990-09-14 | 1992-03-15 | Kenneth Francis Buechler | Anticorps liant aux complexes de recepteurs de ligands et de ligands et leur utilite dans les tests ligand-recepteur |
| US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
| CA2107894C (fr) | 1991-04-10 | 2003-10-14 | Kenneth F. Buechler | Subtances inhibitrices |
| EP0579767B1 (fr) | 1991-04-11 | 2000-08-23 | Biosite Diagnostics Inc. | Nouveaux conjugues et dosages destines a la detection simultanee de ligands multiples |
| US5324634A (en) * | 1992-03-31 | 1994-06-28 | The Research Foundation Of State University Of New York | Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer |
| US6019944A (en) | 1992-05-21 | 2000-02-01 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
| US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
| US5494829A (en) | 1992-07-31 | 1996-02-27 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
| US5824799A (en) | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
| US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
| US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
| US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
| DE602004022150D1 (de) | 2003-03-27 | 2009-09-03 | Childrens Hosp Medical Center | Verfahren und kit zum nachweis des frühstadiums einer nierentubuluszellenverletzung |
| CN1791797A (zh) * | 2003-03-27 | 2006-06-21 | 儿童医院医疗中心 | 用于检测肾小管细胞损伤的早发的方法和试剂盒 |
| US7560244B2 (en) * | 2003-06-04 | 2009-07-14 | Joslin Diabetes Center, Inc. | Method of evaluating a subject for risk or predisposition of reduced renal function over time |
| US20050272101A1 (en) | 2004-06-07 | 2005-12-08 | Prasad Devarajan | Method for the early detection of renal injury |
| US20060003345A1 (en) * | 2004-06-30 | 2006-01-05 | Pfizer Inc | RNA bioassay |
| CN101557825A (zh) * | 2005-08-19 | 2009-10-14 | 森托科尔公司 | 抗蛋白酶解的抗体制剂 |
| WO2007144781A2 (fr) * | 2006-04-21 | 2007-12-21 | Diagnotech Pty. Ltd. | Procédés de diagnostic et trousses utilisant des anticorps dirigés contre des métalloprotéases |
| CN103399155A (zh) * | 2007-03-26 | 2013-11-20 | 诺瓦提斯公司 | 用于监测肾功能的预测性的肾安全性生物标志物和生物标志物标签 |
| ES2475990T5 (es) * | 2007-11-15 | 2017-07-06 | Bioporto Diagnostics A/S | Uso diagnóstico de formas moleculares individuales de un biomarcador |
| CA2716854A1 (fr) | 2008-02-29 | 2009-09-03 | National University Corporation Nagoya University | Biomarqueur pour l'estimation d'un trouble renal aigu et le pronostic du trouble, et utilisation du biomarqueur |
| NZ610356A (en) | 2008-08-28 | 2015-03-27 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CA2735590A1 (fr) * | 2008-08-29 | 2010-03-04 | Astute Medical, Inc. | Procedes et compositions pour le diagnostic et le pronostic de la blessure renale et de l'insuffisance renale |
| NZ607703A (en) * | 2008-10-21 | 2014-09-26 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CN102264230B (zh) * | 2008-11-10 | 2014-12-10 | 阿斯图特医药公司 | 用于诊断和预后肾损伤和肾衰竭的方法和组合物 |
| US9229010B2 (en) * | 2009-02-06 | 2016-01-05 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| EP2438441B1 (fr) * | 2009-06-02 | 2014-05-21 | BIOCRATES Life Sciences AG | Nouveaux biomarqueurs d'evaluation des maladies renales |
| CA2770393A1 (fr) * | 2009-08-07 | 2011-02-10 | Astute Medical, Inc. | Procedes et compositions pour le diagnostic et le pronostic d'une lesion renale et d'une insuffisance renale |
| EA201290106A1 (ru) * | 2009-09-18 | 2012-12-28 | Астьют Медикал, Инк. | Способы и композиции для диагностики и прогнозирования повреждения почек и почечной недостаточности |
| MX2009012633A (es) | 2009-11-23 | 2011-05-24 | Univ Mexico Nacional Autonoma | Metodo de diagnostico para detectar la lesion renal aguda a traves del uso de la proteina de choque termico de 72 kda como un biomarcador sensible. |
| JP5763098B2 (ja) * | 2009-12-20 | 2015-08-12 | アスチュート メディカル，インコーポレイテッド | 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 |
| EP3070474A3 (fr) | 2010-02-26 | 2016-12-07 | Astute Medical, Inc. | Procedes et compositions pour le diagnostic et le pronostic de lesion renale et d'insuffisance renale |
| CN103874923B (zh) * | 2011-08-26 | 2016-09-14 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断及预后的方法和组合物 |
-
2012
- 2012-08-24 CN CN201280049909.5A patent/CN103874923B/zh active Active
- 2012-08-24 JP JP2014527328A patent/JP2014529073A/ja active Pending
- 2012-08-24 PT PT12832845T patent/PT2748605T/pt unknown
- 2012-08-24 CN CN201610804095.1A patent/CN106443011A/zh active Pending
- 2012-08-24 EP EP12832845.7A patent/EP2748605B1/fr active Active
- 2012-08-24 CA CA2846602A patent/CA2846602A1/fr not_active Abandoned
- 2012-08-24 AU AU2012312907A patent/AU2012312907A1/en not_active Abandoned
- 2012-08-24 TR TR2019/03235T patent/TR201903235T4/tr unknown
- 2012-08-24 WO PCT/US2012/052298 patent/WO2013043310A1/fr not_active Ceased
- 2012-08-24 EP EP18209718.8A patent/EP3489690A1/fr active Pending
- 2012-08-24 US US14/241,005 patent/US9459261B2/en active Active
- 2012-08-24 BR BR112014004389A patent/BR112014004389A2/pt not_active IP Right Cessation
- 2012-08-24 PL PL12832845T patent/PL2748605T4/pl unknown
- 2012-08-24 KR KR1020147007890A patent/KR20140074307A/ko not_active Withdrawn
- 2012-08-24 IN IN377MUN2014 patent/IN2014MN00377A/en unknown
- 2012-08-24 EA EA201490384A patent/EA201490384A1/ru unknown
- 2012-08-24 MX MX2014002146A patent/MX346096B/es active IP Right Grant
- 2012-08-24 ES ES12832845T patent/ES2721907T3/es active Active
-
2016
- 2016-10-03 US US15/284,197 patent/US9784750B2/en active Active
- 2016-10-19 JP JP2016204848A patent/JP2017032586A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20140074307A (ko) | 2014-06-17 |
| CN106443011A (zh) | 2017-02-22 |
| EP3489690A1 (fr) | 2019-05-29 |
| US20140213477A1 (en) | 2014-07-31 |
| WO2013043310A1 (fr) | 2013-03-28 |
| EP2748605A4 (fr) | 2015-12-02 |
| US20170016917A1 (en) | 2017-01-19 |
| US9459261B2 (en) | 2016-10-04 |
| BR112014004389A2 (pt) | 2017-03-28 |
| PT2748605T (pt) | 2019-05-03 |
| NZ621716A (en) | 2016-04-29 |
| JP2014529073A (ja) | 2014-10-30 |
| ES2721907T3 (es) | 2019-08-06 |
| PL2748605T3 (pl) | 2019-08-30 |
| TR201903235T4 (tr) | 2019-03-21 |
| MX2014002146A (es) | 2014-08-21 |
| CN103874923B (zh) | 2016-09-14 |
| CA2846602A1 (fr) | 2013-03-28 |
| EP2748605B1 (fr) | 2018-12-05 |
| NZ706242A (en) | 2016-07-29 |
| JP2017032586A (ja) | 2017-02-09 |
| AU2012312907A1 (en) | 2014-03-13 |
| MX346096B (es) | 2017-03-07 |
| US9784750B2 (en) | 2017-10-10 |
| PL2748605T4 (pl) | 2019-08-30 |
| EP2748605A1 (fr) | 2014-07-02 |
| EA201490384A1 (ru) | 2014-08-29 |
| CN103874923A (zh) | 2014-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN00377A (fr) | ||
| MX341926B (es) | Metodos y composiciones para la diagnosis y prognosis de daño renal y falla renal. | |
| EP2539712A1 (fr) | Procédés et compositions pour diagnostic et pronostic de lésion rénale et d'insuffisance rénale | |
| WO2012174282A3 (fr) | Compositions de biomarqueur et procédés associés | |
| EA201290387A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности | |
| WO2014193999A3 (fr) | Méthodes et compositions d'identification de biomarqueurs | |
| WO2009024691A3 (fr) | Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal | |
| EP2813848A3 (fr) | Procédés et compositions pour le diagnostic et le pronostic de lésion rénale et d'insuffisance rénale | |
| MX2014000283A (es) | Metodos y composiciones para diagnóstico y pronóstico de lesión e insuficiencia renal. | |
| EA201291314A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности | |
| MX382244B (es) | Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales | |
| Costa et al. | Emerging molecular biomarker targets for amyotrophic lateral sclerosis | |
| NZ619883A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| WO2008100352A3 (fr) | Diagnostic de melanome metastatique et surveillance d'indicateurs d'immunosuppression par analyse de microreseaux de leucocytes sanguins | |
| JO3764B1 (ar) | جزيئات إرتباط il-18 | |
| EA200970891A1 (ru) | Генетические варианты chr2 и chr16 в качестве маркеров для применения при оценке риска, диагностировании, прогнозировании и лечении рака молочной железы | |
| WO2013022953A3 (fr) | Biomarqueur pour maladie d'alzheimer et/ou trouble léger cognitif, et son utilisation | |
| NZ608316A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| MX336280B (es) | Metodos y composiciones para diagnosticos y pronosticos de lesion renal y falla renal. | |
| EP2723866A4 (fr) | Procédés de pronostic et/ou de diagnostic d'une maladie neurodégénérative, procédés d'identification de composés candidats et composés pour le traitement d'une maladie neurodégénérative | |
| EA201290195A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности | |
| MX388231B (es) | Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal. | |
| MA30393B1 (fr) | Procede de traitement, de diagnostic ou de detection du cancer | |
| MX2012005218A (es) | Metodos y composiciones para el diagnostico y pronostico de daño renal y falla renal. | |
| EP2686437A4 (fr) | Mucine 5b, biomarqueur spécifique des kystes liquidiens du pancréas, utilisable en vue de l'établissement d'un diagnostic précis des kystes mucineux, et autres marqueurs utilisables en vue de la détection d'un cancer du pancréas |